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Abstract 
Long-term potentiation (LTP) in the rat hippocampus is the most extensively studied cellular 
model for learning and memory. Induction of classical LTP involves an NMDA receptor- and 
calcium-dependent increase in functional synaptic AMPA receptors mediated by enhanced 
recycling of internalized AMPA receptors back to the postsynaptic membrane. Here we 
report a novel, physiologically relevant NMDA receptor-independent mechanism that drives 
increased AMPA receptor recycling and LTP. This pathway requires the metabotropic action 
of kainate receptors and activation of G-protein, protein kinase C and phospholipase C. Like 
classical LTP, kainate receptor-dependent LTP recruits recycling endosomes to spines, 
enhances synaptic recycling of AMPA receptors to increase their surface expression and 
elicits structural changes in spines, including increased growth and maturation. These data 
reveal a new and previously unsuspected role for postsynaptic kainate receptors in the 
induction of functional and structural plasticity in the hippocampus.  
Introduction 
The precise dynamic regulation of the number, composition and distribution of postsynaptic 
AMPA receptors (AMPARs) is essential for synaptic transmission and plasticity. Classical 
LTP, which has been characterised extensively in many brain areas, requires the activation 
of NMDA receptors (NMDARs) 1. An equivalent NMDAR-dependent LTP can be induced in 
cultured hippocampal neurons by brief exposure to the NMDAR co-agonist glycine, which 
elicits the insertion of AMPARs into the postsynaptic membrane and increases miniature 
excitatory postsynaptic currents (mEPSCs) 2.  
LTP involves both recycling-dependent increases in AMPAR surface expression at the post-
synaptic membrane and increases in dendritic spine size 3. Furthermore, stimuli that induce 
LTP in dispersed hippocampal neuronal cultures promote recycling and recruitment of 
transferrin receptor-positive recycling endosomes into spines. This repositioning of the 
endosomal-recycling compartment is critical for activity-dependent changes in spine 
morphology and provides a mechanistic link between structural and functional plasticity 3, 4. 
Kainate receptors (KARs) are tetrameric assemblies of combinations of GluK1 – GluK5 
subunits. They are present at both pre- and postsynaptic membranes where they perform 
distinct roles in modulating synaptic transmission, neuronal excitability and network activity 5, 
6, and are implicated in processes ranging from neuronal development and differentiation to 
neurodegeneration and neuronal cell death 5, 7. In addition to direct ionotropic signalling, 
KARs also signal through the activation of G proteins leading to PKC activation 5, 6, 8-10. Under 
physiological glutamate release conditions, postsynaptic KAR metabotropic signalling in CA1 
and CA3 pyramidal neurones inhibits the hyperpolarisation caused by the post-spike 
potassium current I (sAHP) 11-14.  
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We, and others, have shown previously that transient kainate (KA) stimulation modulates 
surface expression of KARs 15-18 via changes in Rab11-dependent recycling within spines 19. 
Here, we report that KA induces an NMDAR-independent increase in the synaptic surface 
expression of functional AMPARs, as well as the structural plasticity via a pathway that 
requires metabotropic signalling of postsynaptic GluK2-containing KARs and enhanced 
endosomal vesicle recycling in spines. 
Results 
KAR activation increases surface expression of functional synaptic AMPARs. 
We first investigated the effects of KA application on AMPAR surface expression in the 
presence of tetrodotoxin (TTX, 0.5 µM), GYKI53655 (40 µM) and L689560 (5 µM) to 
suppress activity-dependent glutamate release and prevent activation of AMPARs and 
NMDARs respectively. Agonist stimulation of KARs (10 µM KA, 3 min) significantly increased 
surface expression of both GluA1 and GluA2 AMPAR subunits (Fig. 1A, one-way ANOVA, 
GluA1 p=0.004 GluA2 p=0.001, GluA1 F(3,8)=10.315, GluA2 F(3,8)=14.62, 3 cultures from 
different animals. GluA1: Median for Control, KA, CNQX, CNQX+KA respectively: 1 1.32, 
1.00, 1.06. 25% for Control, KA, CNQX, CNQX+KA respectively: 1, 1.32, 0.94, 0.90. 75% for 
Control, KA, CNQX, CNQX+KA respectively: 1, 1.36, 1.04, 1.14. GluA2: Median for Control, 
KA, CNQX, CNQX+KA: 1, 1.26, 0.96,1.04. 25% for Control, KA, CNQX, CNQX+KA: 1, 1.19, 
0.95, 0.96. 75% for Control, KA, CNQX, CNQX+KA respectively: 1, 1.28, 1.02, 1.07., 
respectively), without altering the total number of AMPARs (Supplementary Fig.1A-B). This 
KAR-induced increase in plasma membrane expressed AMPARs was blocked by the 
competitive AMPAR/KAR antagonist CNQX (10 µM; Fig. 1A). 
To define if the KAR-induced increase in AMPAR surface expression occurred at spines, we 
immuno-labelled surface expressed GluA1 and GluA2 in non-permeabilised neurons (Fig. 
1B) and calculated the spine/adjacent dendrite ratio. This was increased for both GluA1 and 
GluA2 following KAR stimulation indicating preferential AMPAR surface expression in spines 
(Two samples Kolmogorov-Smirnov, GluR1, Control vs KA p=0.001; CNQX vs CNQX+KA 
p=0.15; control vs CNQX p=0.01; KA vs CNQX+KA p=0.0001; GluR1, Control vs KA: 
D=0.40; CNQX vs CNQX+KA D=0.20; Control vs CNQX D=0.32; KA vs CNQX+KA D=0.51. 
GluR2, control vs KA p=0.01; CNQX vs CNQX+KA p=0.12; Control vs CNQX p= 0.07; KA vs 
CNQX+KA p=0.0001. GluR2, control vs KA D=0.3411; CNQX vs CNQX+Kainate D=0.17; 
Control vs CNQX D=0.260; KA vs CNQX+KA D=0.339, n cells GluR1/2: Control 11; KA 16; 
CNQX 11; CNQX+KA12. Cells from 3 cultures from different animals). Consistent with this, 
KAR-stimulation increased surface GluA1 and GluA2 colocalisation with the postsynaptic 
marker PSD95 (Fig. 1C, One-way ANOVA followed by Tukey test GluR1 p=<0.001, F 
GluR1(3,43)= 46, Tukey test: Control vs KA p= <0.001; CNQX vs KA p=<0.001; CNQX+KA 
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vs KA p=<0.001; Control vs CNQX p=0.98; Control vs CNQX+KA p=0.995. GluR2 p<0.001, 
F GluR2 (3,46)=49, Tukey test: control vs KA p=<0.001, CNQX vs KA p=<0.001; CNQX+KA 
vs KA p=<0.001; Control vs CNQX: P=0.46; CNQX vs CNQX+KA p=0.16 n cells GluR1: 
Control 10; KA 15; CNQX 10; CNQX+KA 12. n cells GluR2: Control 15; KA 15; CNQX 10; 
CNQX+KA 10).  
The increase in synaptic GluA1 and GluA2 was induced by a brief (3 min) exposure of the 
cultured hippocampal neurons to all KA concentrations tested, ranging from 500 nM to 20 µM 
(Supplementary Fig. 1C-D,). We next tested if nanomolar concentrations of KA increased 
postsynaptic AMPAR-mediated mEPSCs in CA1 pyramidal neurons in hippocampal slices. 
KA concentrations below 3 µM do not activate AMPARs in CA1 20, but, to fully exclude direct 
KA activation of AMPARs, we co-applied the AMPAR specific antagonist GYKI53655 (40 
µM) during the transient KA application. GYKI53655 was then washed out to obtain AMPAR 
mEPSCs. Co-application of GYKI53655 with 500 nM KA did not change mEPSC frequency 
(Supplementary Fig. 2A ) but caused a marked increase in the amplitude of mEPSCs (Fig. 
1D and Supplementary Fig. 3A,. Fig. 1D: Two samples Kolmogorov-Smirnov test, Control 
p=0.243856, Control: K-S statistics D=0.073. n=4 cells from 4 different animals. KA p 
=0.0000001, K-S statistic D=0.222. n=5 cells from 4 different animals. Control before (pA): 
25%=14.94, Median=19.37, 75%=30.21; Control after (pA): 25%=13.85, Median=19.63, 
75%=28.32. KA before (pA): 25%=13.01, Median=16.78, %=23.35, KA after (pA): 
25%=14.76, Median =22.23, 75%=29.45. These data demonstrate a KAR-induced increase 
of functional postsynaptic AMPARs.  
KAR-mediated NMDAR-independent LTP. 
Increased postsynaptic AMPARs surface expression underpins LTP, so we investigated the 
effects of KAR activation on synaptically evoked AMPAR-mediated excitatory postsynaptic 
responses in rat hippocampal slices. KA (10 µM, 3 min) caused a transient depression 
followed by a progressive increase in AMPAR-mediated CA1 EPSCs (Supplementary Fig. 
4A;) with no change in glutamate release probability determined by the paired-pulse ratio 
(PPR; Supplementary Fig. 4B) in the continuous presence of 100 µM APV (to block 
NMDARs). At this concentration, however, KA activates AMPARs and could affect their 
dynamics. Thus, we performed the experiment as above, but using 40 µM GYKI53655 
(present prior to and during KA application to block AMPARs). Although in the presence of 
GYKI53655 there was a significant difference in amplitude between the control and KA 
conditions (Supplementary Fig. 4C, unchanged PPRs are shown in Supplementary Fig. 4D 
and representative responses shown in Supplementary Fig. 4E), GYKI53655 masked the 
time course of AMPAR-mediated EPSCs. We therefore reduced the KA concentration to 500 
nM, thereby avoiding the need to block AMPARs with GYKI53655. Under these conditions, 
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500 nM KA caused a progressive and persistent increase in AMPAR-mediated CA1 EPSCs 
Figure 2A; Paired t-test, before vs. after, Control p =0.44, t=-0.857, DF=4, n=5 from 5 
different animals. KA p =0.025, t=-3.16, DF=5, n=6 from 6 different animals), reaching a peak 
approximately 10-15 min after the agonist application. Again, we found no change in PPR 
(Supplementary Fig. 4F). Combined with our mEPSC data, these evoked EPSC results 
indicate that KAR activation elicits NMDAR-independent KA-induced LTP via increased 
surface expression of postsynaptic AMPARs in CA1 hippocampal neurons.  
Consistent with this, KA did not induce any potentiation in AMPAR-mediated field potentials 
in the CA1 region of hippocampal slices from GluK2-knockout (GluK2-/-) mice 
(Supplementary Fig 5A). To exclude any possible developmental effects in the GluK2-
knockout mice, we tested the effect of acutely blocking KARs in wild-type mice using the 
AMPAR/KAR blocker CNQX (10 µM) prior to and during KA challenge, followed by CNQX 
washout (Supplementary Fig. 5B). Compared to sham controls (CNQX only), the recovery 
profile was unchanged (). We also confirmed that KA application potentiated AMPAR 
responses in hippocampal slices obtained from adult, 3-month old mice (Supplementary Fig. 
5C-D), indicating that KA-induced LTP is not developmentally restricted. 
Using wild-type and GluK2-knockout mice, we next examined the KAR dependency of a 
previously reported NMDAR-independent form of LTP evoked by high frequency stimulation 
(HFS) protocol, based on the modified procedure from 21, 22 (illustrated in schematic form in 
Fig. 2B and described in Methods). As shown in Supplementary Fig. 6A-C, field potential 
recordings revealed robust LTP in acute hippocampal slices from wild-type mice (), whereas 
a reduced LTP was obtained in GluK2-knockout mice . To isolate the NMDAR-independent 
component of this LTP, we used 50 µM D-APV, which completely blocked LTP in the GluK2-
knockout, but not in WT mice. For some pairwise comparisons, PPR changes were observed 
(Supplementary Fig. 6D). These data confirm that activation of GluK2-containing KARs by 
synaptically released glutamate induces NMDAR-independent and KAR-dependent 
hippocampal LTP. 
Consistent with previous reports 22, the NMDAR-independent component of this HFS LTP in 
wild-type mice was blocked by the L-type calcium blocker nifedipine (Supplementary Fig. 
7A). As in previous experiments, no change in the PPR was detected (Supplementary Fig. 
7B). 
Although widely used, HFS does not correspond to intrinsic in vivo patterns of hippocampal 
activity. Therefore, to determine if KAR-dependent LTP can be induced by more 
physiological stimuli, we used a protocol based on hippocampal sharp-wave/ripple-like 
stimulation pattern (RL-LTP; illustrated in schematic form in Fig. 2C) 23. In wild-type mice, the 
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RL-LTP protocol resulted in a progressive potentiation that peaked 10-15 min after 
stimulation (Fig. 2D left panel; 166.2 ± 8.5 % vs 101.1 ± 2.9% in test vs control pathway, 
paired t-test, p=<0.001, t=-8.03, DF=7.). In GluK2-knockout mice (Fig. 2D right panel; 
representative traces in Fig. 2E), there was a significantly reduced LTP (paired t-test, 
139.7±7.5 % vs.100.6±2.7% in test vs. control pathway, p=<0.001, t=5.80, DF=7, and 
compared to wild-type mice, p=0.03, unpaired t-test, t=2.35, DF=14.Fig. 2F). Importantly, 
however, while RL-LTP (although at reduced level) was still detected in wild-type mice in the 
presence of 50 µM D-APV (paired t-test, Fig 2D left panel; 120.9±2.3% vs 99.5±2.8% in test 
vs control pathway, p<0.001, t =13.92, DF=4), RL-LTP was completely prevented in GluK2-
knockout mice (paired t-test, 99.1±4.0% vs 99.2±3.8%, test vs control pathway, p=0.98, 
t=0.026, DF=7, and p=0.002 compared to wild-type mice, unpaired t-test, t=4.03, DF=11. WT 
n=8 WT+AP5 n=9, GluK2-/- n=8 GluK2-/-+AP5 n=8 slices, Slices from n animals as follows: 
WT n=8, WT+AP5 n=3, GluK2-/- n=8 GluK2-/-+AP5 n=8. Mice from at least 3 litters per group. 
Median for WT, WT+AP5, Gluk2-/-, Gluk2-/-+AP5: 162.50, 135.43, 120.55, 99.89; 25% or WT, 
WT+AP5, Gluk2-/-, Gluk2-/-+AP5:146.43, 126.69, 118.61, 95.06; 75% or WT, WT+AP5, Gluk2 
-/-, Gluk2-/- +AP5: 187.17, 145.65, 123.73, 104.94) 
D-APV is a competitive antagonist, therefore, to exclude the theoretical possibility that the 
intense RL-LTP stimulation paradigm could lead to glutamate accumulation in synaptic cleft 
that could out-compete D-APV, thereby allowing NMDAR-dependent LTP, we used a 
previously described strategy 24. We first blocked the NMDARs with MK-801 (20 µM), a use-
dependent blocker (in nominal 0 mM Mg2+ aCSF, to facilitate the NMDAR activation). Then, 
once the full blockade was achieved, we reintroduced ordinary aCSF, continuously 
supplemented with MK-801 (20 µM) and D-AP5 (50 µM). Robust potentiation still occurred in 
wild-type mice, further confirming the KAR-dependent component of RL-LTP (Supplementary 
Fig. 7C-D).  
Finally, to further discount any possible confounding developmental issues in GluK2-
knockout mice, we performed the RL-LTP experiment in wild-type mice while acutely 
blocking KARs using CNQX (10 µM, present prior to and during LTP induction, followed by 
washout), similarly to the approach used in Supplementary Fig. 5B. No RL-LTP was induced 
after full inhibition by CNQX, i.e. both test and control pathways gradually recovered with 
similar temporal profiles (Supplementary Fig. 7E,). These results provide compelling 
evidence that physiologically relevant stimulation of GluK2-containing KARs can induce 
NMDAR-independent LTP in the hippocampus.  
Next, using rat hippocampal slices, we performed within-slice comparisons of test and control 
pathway responses to RL-LTP and KA application. First we induced RL-LTP (Supplementary 
Fig. 8A-C). We then subjected the slice to bath application of KA (500 nM, 3 min), which 
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caused a robust increase in control pathway to levels equivalent to the RL-LTP in the test 
pathway. Importantly, however, there was no further increase in the pathway previously 
subjected to RL-LTP. These data also demonstrate that the extent of agonist-induced LTP in 
field recordings is comparable to that achieved by patch-clamp recording.  
Our data from GluK2-/- mice indicate that LTP is not saturated in the presence of D-APV 
because RL-LTP induced significantly stronger LTP in WT mice. In a complementary 
approach, we directly tested if agonist and electrical stimulation-induced KAR-LTP share a 
common mechanism using a previously established occlusion protocol 25 . 
We initially induced RL-LTP in one pathway (black circles, Supplementary Fig. 8D,) and then 
bath applied KA (500 nM, 3 min). As expected, and consistent with the data in 
Supplementary Fig. 8A, the pathway that had not been subjected to RL-LTP was potentiated 
by kainate (white circles, Supplementary Fig. 8D-E,). Importantly, KA did not cause additional 
potentiation in the pathway previously exposed to RL-LTP (black circles,). The stimulation 
intensity of the test pathway (white circles) was then adjusted to normalise it to its basal level 
and the RL-LTP protocol was then delivered to this pathway (Supplementary Fig. 8D-E). 
Since no further potentiation was observed, this inverse occlusion experiment confirms that 
KA-induced potentiation and RL-LTP share a common mechanism.  
KAR activation induces structural plasticity via enhanced endosomal recycling. 
NMDAR-dependent LTP elicits structural changes in spine shape and increased spine size 4. 
Correspondingly, transient KA application robustly increases spine density and maturity (Fig. 
3A-C), More specifically, there are increases in mature spine size (65.1% ± 14%, p= <0.001, 
t=6.767, DF=8, unpaired t-test on the last time point (t=30); Fig. 3A) and numbers of dendritic 
protrusions (68.9% ± 25%, p=0.019, t=2.946, DF=8, unpaired t-test on the last time point 
(t=30); Fig. 3B), as well as enhanced transition from stubby to mushroom spines (p=<0.001, 
unpaired t-test; Fig. 3C).  
NMDAR-dependent LTP also enhances generalised endosomal recycling of cargo proteins 
and membrane within the spine 3, 4. To investigate if the same mechanisms underlie KAR-
dependent LTP, we monitored transferrin-Alexa594 (Tf-A594) labelled recycling endosomes. 
Tf-A594 endosomes distribute mainly at the base of spines in non-stimulated control 
neurons. Following transient KA application, however, Tf-A594 endosomes translocate from 
the dendritic shaft to the spine head (Fig. 4A, unpaired t-test, head Control vs KA p=<0.001 
shaft control vs KA p=<0.001, t(head)=-5.09 with 13 degrees of freedom, t(shaft)=6.13 with 
13 degrees of freedom, n=7 control, 9 KA. 3 cultures from different animals. Median for 
Control head, Control shaft, KA head, KA shaft respectively: 3.846, 77.78, 52.63, 15.79. 25% 
Median for Control head, Control shaft, KA head, KA shaft respectively: 0 52.17, 39.58, 75% 
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Median for Control head, Control shaft, KA head, KA shaft respectively: 15, 82.5, 70.235). 
Furthermore, expression of a dominant negative version of the recycling endosome-
associated small GTPase Rab11 (Rab11dn), which blocks NMDAR-dependent LTP 26, 
prevented the KAR-evoked recruitment of recycling endosomes into spines (Fig. 4B, Head 
for Rab11wt KA vs Rab11dn KA p= <0.001; shaft for Rab11wt KA vs Rab11dn KA p= 
<0.001. Unpaired t-test, t(head)=14.23 with 11 degrees of freedom, t(shaft)=-4.66 with 11 
degrees of freedom. n=7 Rab11wt, 6 Rab11dn, 3 cultures from different animals. Median for 
Rab11wt KA head, Rab11wt KA shaft, Rab11dn KA head, Rab11dn KA shaft: 59.38, 9.38, 
12.45, 40.69. 25% for Rab11wt KA head, Rab11wt KA shaft, Rab11dn KA head, Rab11dn 
KA: 56.15, 4.89, 9.38, 28.57. 75% for Rab11wt KA head, Rab11wt KA shaft, Rab11dn KA 
head, Rab11dn KA: 61.81, 17.76, 14.29) and blocked the increases in the head diameter of 
mushrooms spines (Fig. 4C, Two samples Kolmogorov-Smirnov test, Control (t=0 vs t=30) 
p=0.240 KA(t=0 vs t=30) p=0.001, CNQX (t=0 vs t=30) p=0.29, CNQX+KA (t=0 vs t=30) 
p=0.76, Rab11wt+KA (t=0 vs t=30), p=0.0001 Rab11dn+KA p=0.039; Control (t=0 vs t=30) 
D= 0.193, KA(t=0 vs t=30) D=0.118, CNQX (t=0 vs t=30) D=0.136, CNQX+KA (t=0 vs t=30) 
D= 0.074, Rab11wt+KA (t=0 vs t=30), D=0.144, Rab11dn+KA D=0.084, Control n=4 cells, 
KA n=6 cells, CNQX n=4 cells, CNQX+KA n=4 cells, Rab11wt+ KA n=5 cells, Rab11dn+ KA 
n=5 cells, head diameters of mushroom spines automatically detected in the same cells at 
time zero (t=0) and 30min later (t=30). Cells from at least 3 different cultures (3 different 
animals).  
To confirm the role of recycling in KAR-dependent LTP, we used surface biotinylation assays 
in combination with primaquine to selectively inhibit recycling 27 or monensin to block both 
recycling and lysosomal degradation 28. As expected, both drugs prevented the KAR-induced 
increase in GluA1 and GluA2 surface expression (Supplementary Fig. 9A-B,). We next 
quantified surface expression of GluA1 and GluA2 in spines and adjacent shaft regions. 
Inhibiting recycling with primaquine, monensine or Rab11dn prevented the KAR-induced 
change in the spine:dendrite ratio of AMPAR surface expression (Supplementary Fig. 10A-
C,). These data indicate that both NMDAR- and KAR-dependent LTP require the recruitment 
and enhanced recycling of endosomal vesicles in spines.  
KAR-dependent LTP is mediated via a non-canonical G-protein-associated signalling 
pathway.  
Although some mechanistic details are still lacking, it is now clear that KARs signal via G-
protein-dependent pathways to increase intracellular calcium [Ca2+]i, and activate protein 
kinase C (PKC) and phospholipase C (PLC) 5, 6, 9, 10, 29. Since increased [Ca2+]i is required for 
LTP, 30, 31 we tested the source of [Ca2+]i increase in KAR-dependent LTP using the 
extracellular chelator EDTA and the membrane permeant chelator BAPTA-AM. The 
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presence of BAPTA-AM, but not EDTA, during the KA application blocked the KAR-evoked 
increase in synaptic AMPAR surface expression (Fig. 5A, B; controls without KA shown in 
Supplementary Fig. 11A; GluA1, EDTA+KA n=13, p=0.009, BAPTA-AM+KA n=6, p=0.503, 
U73122+KA p=0.56 n=16, Chelerythrine+KA p=0.54 n=13 ; GluA2 EDTA+KA p=<0.001 
n=12, BAPTA-AM+KA p=0.100, n=12, U73122+KA p=0.32 n=10, Chelerythrine+KA p= 0.78 
n=12, unpaired t-test with controls shown in Fig. 11A) and the associated changes in the 
structural plasticity (Fig. 5C and Supplementary Fig. 11B,). Similarly, preincubation with PKC 
inhibitor chelerythrine or the PLC inhibitor U73122 blocked the KAR-induced increase in 
GluA1 and GluA2 expression at synapses (Fig. 5A, B; controls without KA shown in 
Supplementary Fig. 11A-B; U73122: GluA1 p=0.56; GluA2 p=0.32 ; chelerythrine: GluA1 
p=0.54, GluA2 p=0.78), the increase in the spine size (Fig. 5C: Two samples Kolmogorov-
Smirnov test, EDTA+KA (t=0 vs t=30) p=0.006, BAPTA+KA (t=0 vs t=30) p=0.32, 
U73122+KA (t=0 vs t=30) p=0.44 Chelerythrine+KA (t=0 vs t=30) p=0.47; EDTA+KA (t=0 vs 
t=30) D=0.157; BAPTA+KA (t=0 vs t=30) D=0.102; U73122+KA (t=0 vs t=30) D= 0.093; 
Chelerythrine+KA (t=0 vs t=30) D=0.077; EDTA(t=0 vs t=30) p=0.42; BAPTA (t=0 vs t=30) 
p=0.37; U73122 (t=0 vs t=30) p=0.36; Chelerythrine (t=0 vs t=30) p=0.005; EDTA (t=0 vs 
t=30) D=0.19; BAPTA (t=0 vs t=30) D=0.1404; U73122 (t=0 vs t=30) D=0.1980; 
Chelerythrine (t=0 vs t=30) D=0.2905. EDTA n=4 cells, BAPTA n=4 cells, U73122 n=4 cells, 
Chelerythrine n=4 cells head diameters of mushroom spines automatically detected in the 
same cell at time zero (t=0) and 30min later (t=30). Cells from at least 3 different cultures 
obtained from 3 different animals, Supplementary Fig. 11B), as well as the agonist-evoked 
KAR-dependent LTP in electrophysiological recordings (100.5 ± 1.4%, p=0.15, paired t-test 
t=-1.64, DF=6. n=7 slices from 2 different animals for U73122 and 100.7 ± 5.8%, paired t-test 
p=0.88, t=0.161, DF=5. n=6 slices from 2 different animals for chelerythrine, Fig. 5D, E). 
We also analysed PKC and PLC activity in cells after triggering KAR-dependent LTP. Brief 
KAR stimulation (3 min, 500nM) elicited a nearly 2-fold increase in PLC and PKC activity 
compared to unstimulated cells (Fig. 5F). Furthermore, the extent of PKC activation in KAR-
dependent LTP is similar to stimulation by the phorbol ester PMA (0.5 µM, 3min). The KAR-
induced activation of PKC and PLC was prevented by CNQX and BAPTA-AM, but not by the 
presence of EDTA during KA application (Fig. 5F:PKC: KA vs KA+CNQX p=0.02 t=2.82, 
DF=9; KA vs KA+EDTA p=0.40, t = 0.90, DF=8; KA vs KA+BAPTA-AM p=0.04, t=2.47, 
DF=8; KA vs KA+Chelerythrine p=0.02 t = 2.85, DF=10; KA vs PMA, p=0.85 t=-0.203, DF=8; 
n=4-6, Cells from 4-6 independently treated and processed experiments obtained from 4-6 
different animals. PLC: KA vs KA+CNQX p=0.05, t=0.81, DF=8; KA vs KA+EDTA p=0.45, 
t=0.814, DF=6; KA vs KA+BAPTA-AM p=0.01, t = 3.26, DF=7; KA vs KA+U73122 p=0.03, t = 
2.85, DF=7, n=4-5, Cells from 4-5 different independently treated and processed 
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experiments obtained from 4-5 different animals. One-way ANOVA PKC Median for Control, 
KA, CNQX+KA, EDTA+KA, BAPTA-AM+KA, Chelerythrine+KA, PMA respectively: 1, 1.53, 
0.99, 1.40, 1.01, 0.99, 1.62. 25%: 1, 1.36, 0.85, 1.38, 0.95, 0.85, 1.45. 75%: 1, 1.91, 1.07, 
1.67, 1.08, 1.11, 2.24. PLC Median for Control, KA, CNQX+KA, EDTA+KA, BAPTA-AM+KA, 
U73122+KA respectively: 1, 1.59, 1.02, 1.51, 0.73, 0.89. 25%: 1, 1.33, 0.96, 1.43, 0.52, 0.62. 
75%: 1, 2.28, 1.14, 1.61, 0.96, 1.04). Finally, in addition to EGTA (5 mM) application only 
during KA application, we continuously applied (30 min during and after KA application) the 
selective Ca2+ chelator EGTA to bind extracellular Ca2+ or nifedipine to block L-type voltage-
gated Ca2+ channels (VGCCs). Continuous application of either drug prevented the KA-
induced increase in GluA1 and GluA2 surface expression at synapses (Supplementary Fig. 
11C, D;), suggesting a delayed role for extracellular Ca2+ in KAR-LTP. Importantly, inhibiting 
Group I /II metabotropic glutamate receptors with the specific antagonist MCPG did not affect 
KAR-dependent increases in synaptic AMPARs or spine size. (Supplementary Fig. 12A, B;). 
These data demonstrate that KAR-LTP requires activation of PKC and PLC and intracellular 
calcium release, consistent with a KAR-mediated metabotropic signalling pathway. 
Furthermore, we performed the same experiments as those shown in Figure 1C, but with the 
preincubation in the presence of G-protein inhibitor pertussis toxin (PTX) (1 µg/mL, 1 hour). 
PTX prevented KA-induced activation of both PLC and PKC (Fig. 6A, unpaired t-test, PKC: 
KA vs KA+PTX p=0.01, PLC: KA vs PTX+KA p=0.03; PKC: KA vs PTX+KA. t=3.06 with 10 
degrees of freedom. PLC: kainate vs PTX+KA t=2.70 with 7 degrees of freedom. PKC n=6, 
PLC n=4, Cells from 4-6 independently treated and processed experiments obtained from 4-
6 different animals. PKC: Median for Control, KA, PTX+KA respectively: 1, 1.53,1.06. 25% 
for Control, KA, PTX+KA respectively: 1, 1.37, 0.84. 75% for Control, KA, PTX+KA 
respectively: 1, 1.91, 1.10. PLC Median for Control, KA, PTX+KA respectively: 1, 1.59, 0.99. 
25% for Control, KA, PTX+KA respectively: 1, 1.33, 0.93. 75% for Control, KA, PTX+KA: 1, 
2.28, 1.03). PTX also blocked the increased colocalization of GluA1 and GluA2 with PSD95 
following the KA challenge (Fig. 6B, unpaired t-test, GluR1: PTX vs PTX+KA . p=0.93; 
GluR2: PTX vs PTX+KA p=0.47. GluR1: PTX vs PTX+KA t=0.092 with 20 degrees of 
freedom GluR2: PTX vs PTX+KA t=0.74 with 22 degrees of freedom. GluR1: PTX n=9, 
PTX+KA n=13, GluR2: PTX n=11, PTX+KA n=13, Cells from 3 independently treated and 
processed experiments obtained from 3 different animals, compare with Fig. 1C). 
Furthermore, incubation of hippocampal slices with PTX prior to recording mEPSCs 
prevented the KAR-induced increase in AMPAR mEPSC amplitude in CA1 pyramidal 
neurons (Fig. 6C, Two samples Kolmogorov-Smirnov test, PTX p=0.50, K-S statistic 
D=0.072, n=3 cells from 3 animals; PTX+KA p=0.31, K-S statistic D=0.079, n=3 cells from 3 
animals; PTX before (pA): 25%=15.83, Median=21.0. 75%=27.81; PTX after (pA): 
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25%=16.06, Median=21.58, 75t%=27.53. PTX+KA before (pA): 25%=15.60, Median=22.88, 
75%=39.33. PTX+KA after (pA): 25%=16.23, Median=22.65, 75%=36.63, compare with Fig. 
1D), with no change in the frequency (Supplementary Fig. 13A p>0.1). Correspondingly, 
agonist-evoked and electrically stimulated KAR-dependent LTP (Fig. 6D, unpaired t-test, 
p=0.69, t=-0.42, DF=9, PTX only: n=6 cells; PTX+KA, n=5 cells, Cells from 3 different 
animals. Fig.6E: unpaired t-test, p=0.31, t=1.11, DF=6, n=4 slices from 4 different animals, 
and Supplementary Fig. 13B-D, compare with Fig. 2A), as well as structural plasticity (Fig. 6F 
and Supplementary Fig. 13E, p=0.4, compare with Fig. 3A) were prevented by preincubation 
with PTX, again indicating the requirement for a metabotropic action for KARs.  
Both our imaging and functional data using nifedipine suggest that following initial LTP 
induction that requires intracellular Ca2+, extracellular calcium entry through L-type VGCCs 
plays a role in maintaining KAR-LTP. Moreover, VGCC currents can be modulated by G-
protein activation 32. We therefore used patch-clamp electrophysiology to measure VGCC 
Ca2+ currents. KA application (500 nM, 3 min) increased VGCC currents in control conditions, 
but there was no increase in slices that had been preincubated with PTX (Supplementary 
Fig. 14). 
Substitution of extracellular Na+ with an equimolar concentration of the non-permeant cation 
N-methyl-D-glucamine (NMDG) prevents KAR channel conductance, but does not impede 
metabotropic KAR activity 9. Replacing Na+ with NMDG does not block the KAR-induced 
increase in GluA1 and GluA2 colocalization with PSD95 and spine size (Supplementary 
Fig.15A-B;,further confirming that ionotropic activity is not required for KAR-dependent LTP. 
The KAR antagonist UBP310 has been reported to inhibit KAR ionotropic activity, but not 
KAR-metabotropic signalling, via a mechanism that likely involves an action beyond simple 
competitive antagonism 33. This effect is unlikely to be due to different subunit compositions 
since most KARs in the brain comprise GluK2/5 combinations. We anticipate that future 
studies will uncover the mechanisms underlying this selective inhibition of ionotropic over 
metabotropic KAR activity. Nonetheless, consistent with the documented selectively 
ionotropic action,UBP310 (10 µM) did not block KA-induced increases in PLC and PKC 
activity (Fig. 7A, PLC: KA vs UBP310+kainate: p= 0.74, unpaired t-test, t = -0.35 with 7 
degrees of freedom. n=5 cells from 3 different experiments, PKC: KA vs KA UBP310, p= 
0.94, Mann-Whitney U Statistic, T = 38.0. n(small)=6 n(big)=6, n=6 cells from 3 different 
experiments. PLC Median for control, kainate, UBP310+KA: 1, 1.59, 2.14. 25% or Control, 
KA, UBP310+KA: 1, 1.33, 1.25. 75% or Control, KA, UBP310+KA: 1, 2.28, 2.49. PKC 
Median or Control, KA, UBP310+KA: 1, 1.53, 1.62. 25% or Control, KA, UBP310+KA: 1, 
1.37, 1.46. 75% or control, KA, UBP310+kainate: 1, 1.91, 1.70) nor did it prevent KAR-
dependent LTP (Fig. 7B: p=0.01 UBP310 after KA vs. UBP310 before, paired t-test, t=-4.14, 
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DF=4. n=5 cells from 4 animals Fig. 7C: p=0.004, Unpaired t-test, t=3.65 , DF=10, n=6 slices 
from 6 different animals, Average for last 5 minutes: 131.9 +/- 5.2% vs. 104.7 +/- 5.3% and 
Supplementary Fig.15C-D) and structural spine plasticity (Fig.7D, Two samples Kolmogorov-
Smirnov UBP310+KA t=0 vs t=30: p=0.06, D=0.14, n=4 cells head diameters of mushroom 
spines automatically detected in the same cells at time zero (t=0) and 30min later (t=30). 
Cultures obtained from 3 different animals).  
Taken together, this array of complementary and mutually supportive data provide 
compelling evidence that KAR channel activity is not required for KAR-dependent LTP, but is 
instead underpinned by KAR-mediated metabotropic signalling.  
Discussion 
Here we report that KAR activation can elicit a previously unanticipated form of NMDAR-
independent LTP. This occurs via a metabotropic KAR pathway that recruits endosomal 
recycling machinery from the dendritic shaft into the spine to alter post-endocytic GluA1 and 
GluA2 sorting and exocytosis back to the spine plasma membrane. 
KAR activation increases AMPAR surface expression at postsynapse 
We have shown previously that transient KA application can increase KAR surface 
expression 16 and enhance spine growth by altering post-endocytic sorting and enhanced 
recycling mechanisms 19. Furthermore, KARs regulate neurite outgrowth 16, 34, 35, as well as 
filopodia and nascent spinule development 36. Here we show that transient KAR activation 
augments recycling and surface expression of AMPARs, increases AMPAR colocalisation 
with PSD95 in spines and increases the amplitude of AMPAR mEPSCs. Consistent with 
postsynaptic mechanisms, the probability of neurotransmitter release was unchanged. 
Furthermore, using two different stimulation protocols, we demonstrate that synaptic 
activation of GluK2-containing KARs underlies the increases in the evoked AMPAR-mediated 
responses. These results reveal a novel and physiologically relevant form of postsynaptic 
KAR-dependent, NMDAR-independent LTP. 
KAR activation increases synaptic recycling and spine size  
In parallel with increased AMPAR-mediated neurotransmission, NMDAR-dependent LTP 
elicits the formation and enlargement of dendritic spines to consolidate neural circuitry 37, 38. 
Recycling endosomes are recruited to deliver membrane material directly within spines for 
structural plasticity 3, 4, providing a mechanistic link for coupling changes in spine size to the 
regulation of AMPAR-mediated transmission and LTP 39. Like NMDAR-dependent LTP, KAR-
dependent LTP requires translocation of Rab11-positive recycling endosomes from the 
dendritic shaft into spines. Moreover, overexpression of dominant negative Rab11, which 
blocks NMDAR-dependent LTP 40, prevents the KAR-evoked redistribution of recycling 
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endosomes to spines and blocks KAR-dependent LTP. This involvement of Rab11 in 
NMDAR-dependent and KAR-dependent LTP indicates shared mechanisms in both 
pathways.  
Metabotropic actions of KARs mediate KAR-dependent LTP 
Metabotropic KAR signalling was first identified through the KAR-mediated modulation of 
GABA release, which does not require KAR channel activation, but is prevented by inhibition 
of G-protein and PKC activity 8. Subsequently, KAR-dependent inhibition of the slow after-
hyperpolarizing potential (sAHP), which enhances neuronal excitability, was also shown to 
be mediated by metabotropic KAR signalling 11. Although there is now a wealth of 
experimental support for metabotropic action of both pre- and postsynaptic KARs (for 
reviews see 5, 6, 41), many questions remain. For example, the identity of the KAR subunit 
conferring metabotropic action is unclear because the literature is contradictory and no KAR 
subunits contain conventional G-protein binding motifs. Nonetheless, it is now generally 
accepted that metabotropic KAR signalling is PTX sensitive and thus involves Go rather than 
Gq protein activation. Accordingly, a recent report has suggested that the KAR subunit 
GluK1 can associate directly with a Go protein subunit and that this association is 
responsible for the metabotropic effects of KARs 10. Our results now reveal an entirely novel 
role for metabotropic KAR signalling in regulating AMPAR trafficking, spine morphology and 
NMDAR-independent LTP.  
KAR-dependent LTP  
LTP at CA1 hippocampal synapses is not uniform and comprises a range of NMDAR-
dependent and -independent plasticity mechanisms 42. Given the crucial importance of 
plastic changes in the brain, this array of pathways provides a dynamic, flexible and reliable 
system to ensure the continuity of neuronal network and brain function. Our identification of a 
novel postsynaptic KAR-dependent LTP adds to these important system traits. Ripple-like 
high-frequency patterns of activity (~200 Hz for ~100 ms, repeating at ~1 Hz) occur in 
immobile awake animals and during slow wave sleep 43. These patterns generally occur in 
conjunction with large-amplitude sharp waves and ripple-related activity in vivo is implicated 
in LTP that underlies memory consolidation in the hippocampus 44, 45. Here, we show for the 
first time that this strong and physiologically relevant ripple-like activity LTP induction 
protocol (RL-LTP) is mediated via GluK2-containing KARs. 
It is notable that the induction of KAR-LTP and the previously reported agonist-evoked 
increase in surface expression of GluK2-containing KARs share a similar time course that 
reaches a plateau 10-15 min after stimulation 16. This profile correlates with the delayed 
NMDAR-independent component of HFS-induced LTP 21 and shares dependency on VGCC 
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activation. Moreover, G-protein potentiation of VGCC activity is sensitive to PTX and requires 
PKC activation and increases in [Ca2+]i 32, consistent with KAR-metabotropic actions 
modulating VGCC activity in NMDAR-independent LTP. These features are similar to the role 
of mGluR5 receptor metabotropic signalling which, by facilitating L-type VGCC activity via 
intracellular Ca2+ release, contributes to NMDAR-independent forms of LTP 46. It is important 
to note that the rise in [Ca2+]i, presumably mediated via IP3 receptors, can facilitate VGCC 
activity and that VGCC activity and the influx of extracellular calcium can prolong the 
temporal profile and frequency of intracellular Ca2+-release events 47. This reciprocal 
feedback system fits with our imaging and electrophysiological experiments with nifedipine 
and can extend beyond the kainate stimulation. We anticipate that future work will explore 
this feedback system in more detail by combining simultaneous multiphoton imaging and 
electrophysiology in brain slices. 
Concluding remarks 
Here we describe an entirely new pathway in which direct activation of postsynaptic KARs 
induces LTP. These data show that KAR metabotropic signalling facilitates information 
transfer and synaptic integration by two parallel mechanisms, namely the short-term 
regulation of excitability 13, 14 and long term increase in synaptic efficacy via LTP. Both 
mechanisms are induced by high frequency stimulation of KARs and require PKC. Given that 
KARs are highly expressed during the neuronal circuit formation, and that their dysfunction is 
implicated in many neurological diseases including epilepsy 48 and intellectual disability 49, 
we anticipate that our findings will have far reaching implications. 
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Figure Legends 
 
Fig 1. KA increases AMPAR surface expression. 
A, Immunoblots show the KA-evoked increased surface expression of GluA1 and GluA2, 
which was blocked by CNQX. Data were quantified as % of control, n=3 independent 
experiments. Dot-plots on the right indicated values for the individual experiments. Unless 
otherwise indicated, all imaging and biochemistry experiments are performed in the 
continuous presence of TTX (0.5 µM), GYKI53655 (40 µM) and L689560 (5 µM).  
B, Confocal images showing surface GluA1 and GluA2 in the dendritic shaft and spine (scale 
bar 1 µm) and cumulative frequency plots of spine/dendrite ratios.  
C, Co-localization of GluA1 or GluA2 (red) and PSD95 (green). Scale bar 1 µm. Graphs 
show Pearson´s coefficients for the co-localization. The black line in the whisker plot boxes 
indicates the median.  
D, mEPSCs from CA1 pyramidal cells in hippocampal slices in the continuous presence of 
APV and ± GYKI and ± KA. Quantification of the data using cumulative distribution plots of 
mEPSC amplitudes and whisker plots.  
In all experiments shown in B, C and D, data acquisition and analysis were performed in 
blind with respect to the treatment. 
 
Fig 2. KAR activation induces LTP. 
A, Effects of KA on normalized evoked EPSC amplitudes and sample traces from CA1 
neurons in the presence of D-APV in mice hippocampal slices..  
B-C, Schematic representations of the HFS and the RL-LTP induction protocols. 
D, Normalized fEPSP slope in WT and GluK2-/- mice subjected to RL-LTP. The symbols for 
experiments without APV are squares (black for control and white for test pathway), whereas 
for experiments with APV the symbols are circles (black for control and white for test 
pathway). Arrow indicates point of RL-LTP stimulation.  
E, Representative traces for D.  
F, Normalized fEPSP slope values 21-30 min post LTP protocol.  
In all experiments shown in B, C and D, data acquisition and analysis were performed in 
blind with respect to the treatment or genotype of the animal. 
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Fig 3. KAR-LTP induces structural plasticity. 
A, KAR-induced increase in spine size. Right panel shows quantification of spine area after 
KA (A) / area before KA (A0) versus time. The period of KA application is indicated by the 
black bar. Scale bars 1 µm.  
B-C, Time-lapse experiments showing KA-induced increase in the number of protrusions and 
enhanced transition from stubby to mushroom spines. The number of protrusions was quantified 
before KA application (N0) and at the indicated times (N) in 10 mm segments of dendrites ± KA. The 
period of KA application is indicated by the black bar. The right hand panel of C shows the 
distributions of stubby and mushroom spines in control (black dots) and KA treated cells (white dots) 
at t=30 compared to t=0. Regions where replicate dots that are overlaid in the graph are indicated by 
the arrows. Scale bars 4 µm. In all experiments, data analysis was performed in blind with respect to 
the treatment. 
 
Fig 4. KAR-LTP recruits rab11-recycling endosomes to spines. 
A, KA (red arrow) recruits transferrin-Alexa594 (red) labelled recycling endosomes to spines. 
GFP was expressed to visualise morphology. Time is indicated in seconds. Right panel 
shows the quantification of the proportion of endosomes in head or shaft, Scale bar 1 µm.  
B, Dominant negative Rab11 prevents recruitment of recycling endosomes into spines. Tf-
A488 positive endosomes (green) in neurons expressing RFP-rab11wt or dn (red).. Scale bar 
1 µm.  
C, Images of spines before (t=0) and 30 min (t=30) after KA +/- CNQX in neurons expressing 
GFP, Rab11wt or Rab11dn. Frequency distribution plots of individual spine diameters before 
(black, t=0) and after (grey dotted line, t=30 min) KA. Scale bar 1 µm.  
In all experiments, data analysis was performed in blind with respect to the treatment. 
 
Fig 5. KAR-LTP requires intracellular calcium increase, PKC and PLC activation. 
A-B, BAPTA-AM, U73122 and chelerythrine, but not EDTA, block KAR-mediated increase in 
co-localization of surface GluA1 or GluA2 (red) and PSD95 (green). Scale bar 1 µm. Box-
and-whisker plots show range of Pearson´s coefficient of controls (see also Supplementary 
Fig. 5) and KA treated cells (KA). Black line in the boxes indicates the median. Data analysis 
was performed in blind with respect to the pharmacological treatment. 
C, Images of spines before (t=0) and 30 min (t=30) after indicated drugs +/- KA. Scale bar 1 
µm. Corresponding graphs on the right show frequency distribution of individual spine 
diameters before (black, t=0) and after (grey dotted line, t=30 min) KA.. Note that 
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extracellular chelation of calcium by EDTA does not prevent KAR-mediated increase in 
structural plasticity. Data analysis was performed in blind with respect to the pharmacological 
treatment. 
D-E, Effects of KA on normalized evoked EPSC amplitudes and sample traces from CA1 
neurons in the presence of chelerythrine (upper panel) or the PLC inhibitor U-73122 (bottom 
panel) in mice hippocampal slices.  
F, Box-and-whisker plots show range of fold increase in PLC (right) and PKC (left) activity 
after KA challenge. PLC or PKC activity was normalized to controls in the presence of the 
indicated drugs. Black line in the boxes indicates the median.  
 
Fig 6. KAR-LTP requires KAR metabotropic signalling. 
A, Box-and-whisker plots show range of fold increase in PLC (right) and PKC (left) in cells 
preincubated with PTX. PLC or PKC activity was normalized to control and performed in 
parallel with the experiment in figure 5C. Black line in the boxes indicates the median.  
B, Co-localization of surface GluA1 or GluA2 (red) and PSD95 (green). Scale bar 1 µm. Box-
and-whisker plots of Pearson´s coefficients of colocalization indicate that the metabotropic 
pathway inhibitor PTX blocks KAR-evoked increase in surface AMPARs. Black line in the 
boxes indicates the median.  
C, PTX blocks KAR-mediated increase in CA1 mEPSC amplitude (compare to Fig. 1D). n=3 
cells from 3 animals. Examples of traces pretreated with PTX before and after GYKI53655 
(control) and shown before and after KA plus GYKI53655 (KA+GYKI). Graphs show 
cumulative frequency distribution of mEPSC amplitudes and box-and-whisker plots in insets 
indicating range.  
D, Preincubation with PTX impaired the KA-induced increase of normalized evoked EPSC 
amplitudes in WT mice hippocampal slices (compare with Fig. 2A). Sample traces are shown 
before and after KA challenge.  
E, Normalized fEPSP slope recorded in WT-mice hippocampal slices pretreated with PTX. 
Arrow indicates point of LTP induction. 
F, Images of spines before (t=0) and 30 min (t=30) after KA in cells treated with PTX. Scale 
bar 1 µm. Frequency distribution of individual spine diameters before (black, t=0) and after 
(red, t=30 min) KA. Scale bar 1M. 
In all experiments data analysis was performed in blind with respect to the treatment. 
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Fig 7. KAR-LTP does not require ionotropic KAR activation. 
A, Box-and-whisker plots show fold increase in PLC (right) and PKC activity (left) in the 
presence of the ionotropic KAR inhibitor UBP310 (10 µM). PLC or PKC activity was 
normalized to control and performed in parallel with the experiments in figure 5C. Black line 
in the boxes indicates the median.  
B, UBP310 (10 µM) did not impair the KA-induced increase of normalized evoked EPSC 
amplitudes in WT mice hippocampal slices (compare with Fig. 2A). Sample traces are shown 
before and after KA challenge. 
C, Normalized fEPSP slope recorded in WT mice hippocampal slices in the presence of 
UBP310 (10 µM). Arrow indicates time point of LTP induction. 
D, Images of spines before (t=0) and 30 min (t=30) after KA in cells treated UBP310 (10 µM). 
Scale bar 1 µm. Frequency distribution of individual spine diameters before (black, t=0) and 
after (red, t=30 min) KA. Data analysis was performed in blind with respect to the 
pharmacological treatment. 
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